35867714|t|Stimulation of synaptic activity promotes TFEB-mediated clearance of pathological MAPT/Tau in cellular and mouse models of tauopathies.
35867714|a|Synapses represent an important target of Alzheimer disease (AD), and alterations of their excitability are among the earliest changes associated with AD development. Synaptic activation has been shown to be protective in models of AD, and deep brain stimulation (DBS), a surgical strategy that modulates neuronal activity to treat neurological and psychiatric disorders, produced positive effects in AD patients. However, the molecular mechanisms underlying the protective role(s) of brain stimulation are still elusive. We have previously demonstrated that induction of synaptic activity exerts protection in mouse models of AD and frontotemporal dementia (FTD) by enhancing the macroautophagy/autophagy flux and lysosomal degradation of pathological MAPT/Tau. We now provide evidence that TFEB (transcription factor EB), a master regulator of lysosomal biogenesis and autophagy, is a key mediator of this cellular response. In cultured primary neurons from FTD-transgenic mice, synaptic stimulation inhibits MTORC1 signaling, thus promoting nuclear translocation of TFEB, which, in turn, induces clearance of MAPT/Tau oligomers. Conversely, synaptic activation fails to promote clearance of toxic MAPT/Tau in neurons expressing constitutively active RRAG GTPases, which sequester TFEB in the cytosol, or upon TFEB depletion. Activation of TFEB is also confirmed in vivo in DBS-stimulated AD mice. We also demonstrate that DBS reduces pathological MAPT/Tau and promotes neuroprotection in Parkinson disease patients with tauopathy. Altogether our findings indicate that stimulation of synaptic activity promotes TFEB-mediated clearance of pathological MAPT/Tau. This mechanism, underlying the protective effect of DBS, provides encouraging support for the use of synaptic stimulation as a therapeutic treatment against tauopathies.Abbreviations: 3xTg-AD: triple transgenic AD mice; AD: Alzheimer disease; CSA: cyclosporine A; DBS: deep brain stimulation; DIV: days in vitro; EC: entorhinal cortex; FTD: frontotemporal dementia; gLTP: glycine-induced long-term potentiation; GPi: internal segment of the globus pallidus; PD: Parkinson disease; STN: subthalamic nucleus; TFEB: transcription factor EB.
35867714	42	46	TFEB	Gene	21425
35867714	87	90	Tau	Gene	4137
35867714	107	112	mouse	Species	10090
35867714	123	134	tauopathies	Disease	MESH:D024801
35867714	178	195	Alzheimer disease	Disease	MESH:D000544
35867714	197	199	AD	Disease	MESH:D000544
35867714	287	289	AD	Disease	MESH:D000544
35867714	368	370	AD	Disease	MESH:D000544
35867714	468	506	neurological and psychiatric disorders	Disease	MESH:D001523
35867714	537	539	AD	Disease	MESH:D000544
35867714	540	548	patients	Species	9606
35867714	747	752	mouse	Species	10090
35867714	763	765	AD	Disease	MESH:D000544
35867714	770	793	frontotemporal dementia	Disease	MESH:D057180
35867714	795	798	FTD	Disease	MESH:D057180
35867714	894	897	Tau	Gene	4137
35867714	928	932	TFEB	Gene	21425
35867714	934	957	transcription factor EB	Gene	21425
35867714	1096	1099	FTD	Disease	MESH:D057180
35867714	1111	1115	mice	Species	10090
35867714	1147	1153	MTORC1	Gene	18392
35867714	1205	1209	TFEB	Gene	21425
35867714	1253	1256	Tau	Gene	4137
35867714	1341	1344	Tau	Gene	4137
35867714	1419	1423	TFEB	Gene	21425
35867714	1448	1452	TFEB	Gene	21425
35867714	1478	1482	TFEB	Gene	21425
35867714	1527	1529	AD	Disease	MESH:D000544
35867714	1530	1534	mice	Species	10090
35867714	1591	1594	Tau	Gene	4137
35867714	1627	1644	Parkinson disease	Disease	MESH:D010300
35867714	1645	1653	patients	Species	9606
35867714	1659	1668	tauopathy	Disease	MESH:D024801
35867714	1750	1754	TFEB	Gene	21425
35867714	1795	1798	Tau	Gene	4137
35867714	1957	1968	tauopathies	Disease	MESH:D024801
35867714	1989	1991	AD	Disease	MESH:D000544
35867714	2011	2013	AD	Disease	MESH:D000544
35867714	2014	2018	mice	Species	10090
35867714	2020	2022	AD	Disease	MESH:D000544
35867714	2024	2041	Alzheimer disease	Disease	MESH:D000544
35867714	2043	2046	CSA	Chemical	MESH:D016572
35867714	2048	2062	cyclosporine A	Chemical	MESH:D016572
35867714	2136	2139	FTD	Disease	MESH:D057180
35867714	2141	2164	frontotemporal dementia	Disease	MESH:D057180
35867714	2172	2179	glycine	Chemical	MESH:D005998
35867714	2258	2260	PD	Disease	MESH:D010300
35867714	2262	2279	Parkinson disease	Disease	MESH:D010300
35867714	2307	2311	TFEB	Gene	21425
35867714	2313	2336	transcription factor EB	Gene	21425
35867714	Negative_Correlation	21425	4137

